These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 3700378

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The role of mitochondrial matrix enzymes in the metabolism and toxicity of cysteine conjugates.
    Stevens JL, Ayoubi N, Robbins JD.
    J Biol Chem; 1988 Mar 05; 263(7):3395-401. PubMed ID: 3343250
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide.
    Lash LH, Sausen PJ, Duescher RJ, Cooley AJ, Elfarra AA.
    J Pharmacol Exp Ther; 1994 Apr 05; 269(1):374-83. PubMed ID: 8169843
    [Abstract] [Full Text] [Related]

  • 6. Cellular effects of reactive intermediates: nephrotoxicity of S-conjugates of amino acids.
    Anders MW, Elfarra AA, Lash LH.
    Arch Toxicol; 1987 Apr 05; 60(1-3):103-8. PubMed ID: 3304202
    [Abstract] [Full Text] [Related]

  • 7. L-alanine-glyoxylate aminotransferase II of rat kidney and liver mitochondria possesses cysteine S-conjugate beta-lyase activity: a contributing factor to the nephrotoxicity/hepatotoxicity of halogenated alkenes?
    Cooper AJ, Krasnikov BF, Okuno E, Jeitner TM.
    Biochem J; 2003 Nov 15; 376(Pt 1):169-78. PubMed ID: 12859250
    [Abstract] [Full Text] [Related]

  • 8. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product compound A in human, nonhuman primate, and rat kidney cytosol and mitochondria.
    Iyer RA, Anders MW.
    Anesthesiology; 1996 Dec 15; 85(6):1454-61. PubMed ID: 8968194
    [Abstract] [Full Text] [Related]

  • 9. Human mitochondrial and cytosolic branched-chain aminotransferases are cysteine S-conjugate beta-lyases, but turnover leads to inactivation.
    Cooper AJ, Bruschi SA, Conway M, Hutson SM.
    Biochem Pharmacol; 2003 Jan 15; 65(2):181-92. PubMed ID: 12504794
    [Abstract] [Full Text] [Related]

  • 10. Mitochondrial aspartate aminotransferase catalyses cysteine S-conjugate beta-lyase reactions.
    Cooper AJ, Bruschi SA, Iriarte A, Martinez-Carrion M.
    Biochem J; 2002 Nov 15; 368(Pt 1):253-61. PubMed ID: 12137566
    [Abstract] [Full Text] [Related]

  • 11. High-performance liquid chromatography-fluorescence assay of pyruvic acid to determine cysteine conjugate beta-lyase activity: application to S-1,2-dichlorovinyl-L-cysteine and S-2-benzothiazolyl-L-cysteine.
    Stijntjes GJ, te Koppele JM, Vermeulen NP.
    Anal Biochem; 1992 Nov 01; 206(2):334-43. PubMed ID: 1443603
    [Abstract] [Full Text] [Related]

  • 12. Renal cysteine conjugate beta-lyase-mediated toxicity studied with primary cultures of human proximal tubular cells.
    Chen JC, Stevens JL, Trifillis AL, Jones TW.
    Toxicol Appl Pharmacol; 1990 May 01; 103(3):463-73. PubMed ID: 2339419
    [Abstract] [Full Text] [Related]

  • 13. A purified cysteine conjugate beta-lyase from rat kidney cytosol. Requirement for an alpha-keto acid or an amino acid oxidase for activity and identity with soluble glutamine transaminase K.
    Stevens JL, Robbins JD, Byrd RA.
    J Biol Chem; 1986 Nov 25; 261(33):15529-37. PubMed ID: 3782077
    [Abstract] [Full Text] [Related]

  • 14. Quantitation of multiple pathways for the metabolism of nephrotoxic cysteine conjugates using selective inhibitors of L-alpha-hydroxy acid oxidase (L-amino acid oxidase) and cysteine conjugate beta-lyase.
    Stevens JL, Hatzinger PB, Hayden PJ.
    Drug Metab Dispos; 1989 Nov 25; 17(3):297-303. PubMed ID: 2568912
    [Abstract] [Full Text] [Related]

  • 15. Mutagenicity of amino acid and glutathione S-conjugates in the Ames test.
    Vamvakas S, Elfarra AA, Dekant W, Henschler D, Anders MW.
    Mutat Res; 1988 Sep 25; 206(1):83-90. PubMed ID: 2901035
    [Abstract] [Full Text] [Related]

  • 16. Purification and characterization of human kidney cytosolic cysteine conjugate beta-lyase activity.
    Lash LH, Nelson RM, Van Dyke RA, Anders MW.
    Drug Metab Dispos; 1990 Sep 25; 18(1):50-4. PubMed ID: 2139845
    [Abstract] [Full Text] [Related]

  • 17. The effect of haloalkene cysteine conjugates on rat renal glutathione reductase and lipoyl dehydrogenase activities.
    Lock EA, Schnellmann RG.
    Toxicol Appl Pharmacol; 1990 Jun 01; 104(1):180-90. PubMed ID: 2360207
    [Abstract] [Full Text] [Related]

  • 18. Cysteine conjugate toxicity, metabolism, and binding to macromolecules in isolated rat kidney mitochondria.
    Hayden PJ, Stevens JL.
    Mol Pharmacol; 1990 Mar 01; 37(3):468-76. PubMed ID: 2314393
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intranephron distribution of cysteine S-conjugate beta-lyase activity and its implication for hexachloro-1,3-butadiene-induced nephrotoxicity in rats.
    Kim HS, Cha SH, Abraham DG, Cooper AJ, Endou H.
    Arch Toxicol; 1997 Mar 01; 71(3):131-41. PubMed ID: 9049049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.